This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Congenital dyserythropoietic anemia type IV" – news · newspapers · books · scholar · JSTOR (May 2020) (Learn how and when to remove this message)

Congenital dyserythropoietic anemia type IV
Specialty	Hematology

Congenital dyserythropoietic anemia type IV (CDA IV) has been described with typical morphologic features of CDA II but a negative acidified-serum test.^[1]

CDA type IV is characterized by mild to moderate splenomegaly. Hemoglobin is very low and patients are transfusion dependent. MCV is normal or mildly elevated. Erythropoiesis is normoblastic or mildly to moderately megaloblastic. Nonspecific erythroblast dysplasia is present.^[2]

Congenital dyserythropoietic anemia type IV is an autosomal dominant inherited red blood cell disorder characterized by ineffective erythropoiesis and hemolysis resulting in anemia. Circulating erythroblasts and erythroblasts in the bone marrow show various morphologic abnormalities. Affected individuals with CDAN4 also have increased levels of fetal hemoglobin.^[3]

This section is empty. You can help by adding to it. (December 2017)

Treatment consists of frequent blood transfusions and chelation therapy. Potential cures include bone marrow transplantation and gene therapy.

• Congenital dyserythropoietic anemia
• Thalassemia
• Hemoglobinopathy
• List of hematologic conditions

• Congenital dyserythropoietic anemia at the US National Institutes of Health Home Genetic Reference]